Hormone replacement therapy, reproductive history, and colon cancer: A multicenter, case-control study in the United States

Cancer Causes and Control

Volumn 8, Issue 2, 1997, Pages 146-158

  Kampman, Ellen ^a   Potter, John D ^a,d   Slattery, Martha L ^b   Caan, Bette J ^c   Edwards, Sandra ^b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c KAISER PERMANENTE   (United States)

^d NONE   (United States)

Author keywords

colon cancer; hormone replacement therapy; reproductive history; risk factors; United States; women

Indexed keywords

ACETYLSALICYLIC ACID; ESTROGEN;

ADULT; AGED; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CLINICAL TRIAL; COLON CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HORMONAL THERAPY; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; REPRODUCTION; UNITED STATES;

ADULT; AGE DISTRIBUTION; AGED; CASE-CONTROL STUDIES; COLONIC NEOPLASMS; CONFIDENCE INTERVALS; ESTROGEN REPLACEMENT THERAPY; FEMALE; HEALTH BEHAVIOR; HUMANS; INCIDENCE; MIDDLE AGED; ODDS RATIO; REPRODUCTION; RISK FACTORS; SURVIVAL RATE; UNITED STATES;

EID: 0030942905     PISSN: 09575243     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018459911147     Document Type: Article

References (47)

1. Fraumeni JF Jr, Lloyd JW, Smith EM, Wagoner JK. Cancer mortality among nuns: role of marital status in etiology of neoplastic disease in women. JNCI 1969; 42: 455-67.
2. McMichael AJ, Potter JD. Reproduction, endogenous and exogenous sex hormones, and colon cancer: A review and hypothesis. JNCI 1980; 65: 1201-7.
3. Potter JD, Slattery ML, Bostick RM, Gapstur SM. Colon cancer: a review of the epidemiology. Epidemiol Rev 1993; 15: 499-545.
4. Potter JD. Hormones and colon cancer [Editorial]. JNCI 1995; 87: 1039-40.
5. Wu-Williams AH, Lee M, Whittemore AS, et al. Reproductive factors and colorectal cancer risk among Chinese females. Cancer Res 1991; 51: 2307-11.
6. Davis FG, Furner SE, Persky V, Koch M. The influence of parity and exogenous female hormones on the risk of colorectal cancer. Int J Cancer 1989; 43: 587-90.
7. Slattery ML, Potter JD, Sorenson AW. Age and risk factors for colon cancer (United States and Australia): Are there implications for understanding differences in case-control and cohort studies? Cancer Causes Control 1994; 5: 557-63.
8. Kvåle G, Heuch I. Is the incidence of colorectal cancer related to reproduction? A prospective study of 63,000 women. Int J Cancer 1991; 47: 390-5.
9. Broeders MJM, Lambe M, Baron JA, Leon DA. History of childbearing and colorectal cancer risk in women aged less than 60: an analysis of Swedish routine registry data 1960-1984. Int J Cancer 1996; 66: 170-5.
10. Slattery ML, Mineau GP, Kerber RA. Reproductive factors and colon cancer: the influences of age, tumor site, and family history on risk (Utah, United States). Cancer Causes Control 1995; 6: 332-8.
11. Furner SE, Davis GD, Nelson RL, Haenszel W. A case-control study of large bowel cancer and hormone exposure in women. Cancer Res 1989; 49: 4936-40.
12. Gerhardsson de Verdier M, London S. Reproductive factors, exogenous female hormones, and colorectal cancer by subsite. Cancer Causes Control 1992; 3: 355-60
13. Jacobs EJ, White E, Weiss NS. Exogenous hormones, reproductive history, and colon cancer (Seattle, Washington, USA). Cancer Causes Control 1995; 5: 359-66.
14. Calle EE, Miracle-McMahill HL, Thun MJ, Heath CW. Estrogen replacement therapy and risk of fatal colon cancer in a prospective cohort of postmenopausal women. JNCI 1995; 87: 517-23.
15. Chute CG, Willett WC, Colditz GA, Stampfer MJ, Rosner B, Speizer FE. A prospective study of reproductive history and exogenous estrogens on the risk of colorectal cancer in women. Epidemiology 1991; 2: 201-7.
16. Marcus PM, Newcomb PA, Young T, Storer BE. The association of reproductive and menstrual characteristics and colon and rectal cancer risk in Wisconsin women. Ann Epidemiol 1995; 5: 303-9.
17. Newcomb PA, Storer BE. Postmenopausal hormone use and risk of large bowel cancer. JNCI 1995; 87: 1067-71.
18. Folsom AR, Mink PJ, Sellers TA, Hong CP, Zheng W, Potter JD. Hormone replacement therapy and morbidity and mortality in a prospective study of postmenopausal women. Am J Public Health 1995; 85: 1128-32.
19. Fernandez E, La Vecchia C, A'Avanzo B, Franceschi S, Negri E, Parazzini F. Oral contraceptives, hormone replacement therapy and the risk of colorectal cancer. Br J Cancer 1996; 73: 1431-6.
20. Grodstein F, Martinez ME, Giovannucci EL, et al. Post-menopausal hormone use and colorectal cancer in the Nurses' Health Study. Am J Epidemiol 1996; 143: S63.
21. Weiss NS, Daling JR, Chow WH. Incidence of cancer of the large bowel in relation to reproductive and hormonal factors. JNCI 1981; 67: 57-60.
22. Wu AH, Paganini-Hill RA, Ross RK, et al. Alcohol, physical activity and other risk factors for colorectal cancer: a prospective study. Br J Cancer 1987; 55: 687-94.
23. Wu-Williams AH, Lee M, Whittemore AS, et al. Reproductive factors and colorectal cancer risk among Chinese females. Cancer Res 1991; 51: 2307-11.
24. Risch HA, Howe GR. Menopausal hormone use and colorectal cancer in Saskatchewan: a record linkage cohort study. Cancer Epidemiol Biomark Prev 1995; 4: 21-8.
25. Peters RK, Pike MC, Chang WWL, Mack MT. Reproductive factors and colon cancer. Br J Cancer 1990; 61: 741-8.
26. Troisi R, Schairer C, Chow W-H, Schatzkin A, Brinton LA, Fraumeni JF Jr. A prospective study of menopausal hormones and risk of colorectal cancer (United States). Cancer Causes Control 1997; 8: 130-8.
27. Potter JD, McMichael AJ. Large bowel cancer in women in relation to reproductive and hormonal factors: a case-control study. JNCI 1983; 71: 703-9.
28. Derby CA, Hume AL, Barbour MM, McPhillips JB, Lasater TM, Carleton RA. Correlates of post-menopausal estrogen use and trends through the 1980s in two southeastern New England communities. Am J Epidemiol 1993; 137: 1125-35.
29. Percy C, Van Holten V, Muir C, eds. International Classification of Diseases for Oncology, Second Edition. Geneva, Switzerland: World Health Organization, 1990.
30. Slattery ML, Potter J, Caan B, et al. Energy balance and colon cancer - beyond physical activity. Cancer Res 1997; 57: 75-80.
31. Slattery ML, Edwards SL, Caan BJ, Kerber RA, Potter JD. Response rates among control subjects in case-control studies. Ann Epidemiol 1995; 5: 245-9.
32. Edwards S, Slattery ML, Mori M, et al. Objective system for interviewer performance evaluation for use in epidemiologic studies. Am J Epidemiol 1994; 140: 1020-8.
33. Micozzi MS, Albanes D, Jones Y, Chumlea WC. Correlations of body mass indices with weight, stature, and body composition in men and women in NHANES I and II. Am J Clin Nutr 1986; 44: 725-31.
34. McDonald A, Van Horn L, Slattery ML, et al, The CARDIA dietary history, development and implementation. J Am Diet Assn 1991; 91: 1104-200.
35. Liu K, Slattery ML, Jacobs DR, et al. The reliability and relative validity of the CARDIA diet history. J Ethnic Dis 1994; 4: 15-27.
36. Sidney S, Jacobs DR, Haskell W, et al. Comparison of two methods of assessing physical activity in the CARDIA study. Am J Epidemiol 1991; 133: 1231-45.
37. SAS Institute Inc. SAS/STAT User's Guide Version 6, Fourth Edition, Volume 2. Cary, NC (USA): SAS Institute Inc., 1990.
38. Breslow NE, Day NE. Statistical Methods in Cancer Research. Vol I. The Analysis of Case Control Studies. Lyon, France: International Agency for Research on Cancer, 1980; IARC Sci. Pub. No. 32.
39. Harlow SD, Linet MS. Agreement between questionnaire data and medical records. The evidence for accuracy of recall. Am J Epidemiol 1989; 129: 233-48.
40. Goodman MT, Nomura AM, Wilkens LR, et al. Agreement between interview information and physician records on history of menopausal estrogen use. Am J Epidemiol 1990; 131: 815-25.
41. Kampman E, Giovannucci E, Van 't Veer P, et al. Calcium, vitamin D, dairy foods, and the occurrence of colorectal adenomas among men and women in two prospective studies. Am J Epidemiol 1994; 191: 16-29.
42. Giovannucci E, Egan KM, Hunter DJ, et al. Aspirin and the risk of colorectal cancer in women. New Engl J Med 1995; 333: 609-14.
43. Potter JD, Bostick RM, Grandits GA, et al. Hormone replacement therapy is associated with lower risk of adenomatous polyps of the large bowel: the Minnesota CPRU Case-Control Study. Cancer Epidemiol Biomark Prev 1996; 5: 779-84.
44. McKeown-Eyssen G. Epidemiology of colorectal cancer revisited: are serum triglycerides and/or plasma glucose associated with risk? Cancer Epidemiol Biomark Prev 1994; 3: 687-95.
45. McMichael AJ, Potter JD. Host factors in carcinogenesis: certain bile-acid metabolic profiles that selectively increase the risk of proximal colon cancer. JNCI 1985; 75: 185-91.
46. Issa JPJ, Ottaviano YL, Celano P, Hamilton SR, Davidson NE, Baylin SB. Methylation of the oestrogen receptor CpG island links aging and neoplasia in human colon. Nat Genet 1994; 7: 536-40.
47. Wysowski DK, Golden L, Burke L. Use of menopausal estrogens and medroxyprogesterone in the United States, 1982-1992. Obstet Gynecol 1995; 85: 6-10.